| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 07/01/2008 | US7393920 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving |
| 07/01/2008 | US7393909 Porous, molecularly imprinted polymer and a process for the preparation thereof |
| 07/01/2008 | US7393698 Which have acrylic amide polymer immobilized thereto; heat shock proteins |
| 07/01/2008 | US7393654 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design |
| 06/26/2008 | WO2008074230A1 Interferon alpha mutant and its polyethylene glycol derivative |
| 06/26/2008 | US20080153112 identification of a predominant ligand of CD8+ T cells that are responsible eq for type 1 diabetes. That ligand is islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Several CD8+ T cell-binding peptides from IGRP are identified, including the peptide comprising amino acids |
| 06/26/2008 | US20080153082 Improved stability in high salt concentration solutions, buffers; biosensors; non-nucleotide polyphosphate polymer with a recognition probe conjugated thereto; e.g. polyanion-gold nanoparticle conjugates |
| 06/25/2008 | EP1015027B1 Process for preparing conjugate vaccines including free protein |
| 06/25/2008 | CN101208357A Affinity ligands |
| 06/25/2008 | CN101208353A Isoforms of brain natriuretic peptide |
| 06/24/2008 | US7390888 Dendritic cell potentiation |
| 06/24/2008 | US7390887 Antibodies against PRO4330 |
| 06/24/2008 | US7390886 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders |
| 06/24/2008 | US7390883 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells/adipocytes; for stimulating the release of proteoglycans from cartilage |
| 06/24/2008 | US7390878 PRO6090 polypeptides |
| 06/24/2008 | US7390877 Vectors with DNA encoding pro polypeptides |
| 06/24/2008 | US7390876 Identification and isolation of novel DNA and recombinant production of novel polypeptides |
| 06/24/2008 | US7390873 Microbiocides; bactericides |
| 06/24/2008 | US7390784 Binary complexes formed have an enlarged target binding surface area and thus exhibit increased affinity, specificity or selectivity as compared to free drug forms |
| 06/24/2008 | US7390498 implanting matrix for bioactive material which is biocompatible porous forms of beta -tricalcium phosphate granules support the development of new bone throughout its structural form, together with bone morphogenic protein as bioactive material |
| 06/24/2008 | US7390486 PRO4381 antibodies |
| 06/19/2008 | WO2008070927A1 Multimeric fc receptor polypeptides including a modified fc domain |
| 06/19/2008 | US20080146513 Synthetic Ion Channels |
| 06/19/2008 | US20080146494 Glycoconjugation methods and proteins/peptides produced by the methods |
| 06/19/2008 | US20080146459 Protein Array and Process for Producing the Same |
| 06/19/2008 | CA2671732A1 Multimeric fc receptor polypeptides including a modified fc domain |
| 06/17/2008 | CA2117193C Vaccine comprising part of constant region of ige for treatment of ige-medicated allergic reactions |
| 06/13/2008 | CA2598913A1 Incorporation of biomolecules in thin films |
| 06/11/2008 | EP1928917A2 Omega-3 fatty acids encapsulated in zein coatings and food products incorporating the same |
| 06/11/2008 | EP1012289B1 A Recombinant Expression Vector of Human Parathyroid Hormone |
| 06/11/2008 | CN100393881C Structural body containing polyhydroxy chain alkyl ester and its production method |
| 06/10/2008 | US7385053 Functionalized compositions for improved immobilization |
| 06/10/2008 | US7385031 PRO6097 polypeptides |
| 06/10/2008 | US7385030 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 06/05/2008 | WO2008067271A2 Prevention of leaching of ligands from affinity-based purification systems |
| 06/05/2008 | WO2007075899A3 Dual agonist compounds and uses thereof |
| 06/04/2008 | CN100391979C Mono methoxy polyethylene glycol-insulin complex substance and its preparation method |
| 06/04/2008 | CN100391976C High efficiency low poison immune toxin and its preparation method and application |
| 06/03/2008 | US7383135 C-Jun N-terminal kinase 3 alpha; determining the three-dimensional atomic coordinates of an active site binding pocket of the kinase crystal by X-ray diffraction; using the structure to design or select a potential inhibitor; synthesizing the inhibitor; and determining its bioactivity |
| 06/03/2008 | US7381789 Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers |
| 06/03/2008 | US7381552 Hydrophilic polymer immobilized with active materials |
| 06/03/2008 | US7381534 Immunoglobulin binding immunogenic polypeptide of given sequence; test kits for allergy detection |
| 05/29/2008 | WO2008061363A1 Biomolecule compatible silica particles |
| 05/29/2008 | WO2008030253A3 Multilayer films, coatings and microcapsules comprising polypeptides |
| 05/29/2008 | WO2007143161A3 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods |
| 05/29/2008 | US20080125332 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation |
| 05/29/2008 | US20080124812 Mixture comprising ligand immobilized solid support for isolating lysosomal enzyme components |
| 05/29/2008 | CA2670830A1 Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| 05/28/2008 | EP1009759B1 Carbohydrate crosslinked glycoprotein crystals |
| 05/28/2008 | CN100390193C Methods and reagents for detecting endotoxin |
| 05/27/2008 | US7378502 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 05/27/2008 | US7378487 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 05/22/2008 | WO2008059837A1 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins |
| 05/22/2008 | WO2008058963A1 Immobilization of membrane proteins onto supports via an amphiphile |
| 05/22/2008 | WO2008058461A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 05/22/2008 | WO2008058302A1 S-layer protein covered surfaces |
| 05/22/2008 | CA2668906A1 Membranous protein immobilisation on a carrier using an amphiphile molecule |
| 05/22/2008 | CA2666182A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 05/21/2008 | EP1360202B1 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 05/21/2008 | CN101184779A Compounds and methods for peptide synthesis |
| 05/20/2008 | US7375196 PRO19814 antibodies |
| 05/20/2008 | US7375195 Vectors with DNA encoding pro polypeptides |
| 05/20/2008 | US7375183 identification of differentiation antigen termed mesothelin found on tumor cells, particularly mesotheliomas and ovarian tumor; targeting cells bearing the antigen; its expression level is an indication of the presence of tumor cells |
| 05/20/2008 | US7375179 PRO19680 polypeptides |
| 05/20/2008 | US7374894 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
| 05/20/2008 | US7374764 CD33-like protein |
| 05/15/2008 | WO2008012542A3 Polysaccharide derivatives of erythropoietin |
| 05/15/2008 | US20080113923 cubic liquid crystal formulation containing an amphiphilic compound such as 1-O-(5,9,13-trimethyltetradecyl)erythritol and a drug ( excluding a lysosomal enzyme) or cosmetic embedded in the cubic liquid crystal; time release agent |
| 05/15/2008 | US20080113905 Biologically active peptide with extended half-life and a slower clearance compared to unPEGylated peptide; PEGylated GLP-1 compounds treat diabetes, obesity, irritable bowel syndrome |
| 05/14/2008 | EP1919956A1 Gelation of undenatured proteins with polysaccharides |
| 05/14/2008 | EP1919503A2 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 05/14/2008 | EP1919491A2 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 05/13/2008 | US7371827 Antibodies against the PRO1126 polypeptide |
| 05/13/2008 | US7371824 PRO6093 polypeptides |
| 05/13/2008 | US7371815 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 05/13/2008 | US7371572 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection |
| 05/13/2008 | US7371373 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 05/13/2008 | US7371372 Inosine monophosphate dehydrogenase inhibitor and interferon; hepatitis C |
| 05/13/2008 | US7371364 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
| 05/13/2008 | CA2302147C Methods for protein screening |
| 05/08/2008 | WO2008052428A1 Preparation method and conjugate with drug molecule thereof |
| 05/08/2008 | WO2008028206A3 Method for producing reactive monolayer units |
| 05/08/2008 | WO2006076691A8 Irta-2 antibodies and their uses |
| 05/08/2008 | US20080108557 Conjugating peptides and proteins using glycosyltransferase; nontoxic; increasing bioactivity |
| 05/08/2008 | US20080108123 Fe2O3 complexed biopolymer matrix for use in separation, isolation and delivery of cells, bacteria, drug elements; drug screening |
| 05/08/2008 | CA2656112A1 Bioresponsive polymers |
| 05/07/2008 | CN101173029A Method for producing western blot resin with dual recognition group polymer chain and application thereof |
| 05/07/2008 | CN101173028A Method for producing western blot resin with kation recognizing group and application thereof |
| 05/07/2008 | CN100386342C Method for preparing carbon nanotube-protein stationary phase |
| 05/06/2008 | US7368540 Given amino acid sequence; testing substance's ability to interact with complex; mutants used in crop protection and/or soil treatment |
| 05/06/2008 | US7368532 A non-toxic polypeptide containing a binding domain that binds to the neuronal cell and a translocation domain that translocates the therapeutic agent into the neuronal cell; clostridial neurotoxins |
| 05/06/2008 | US7368530 Human intestinal Npt2B |
| 05/06/2008 | US7368529 Protein isolated from plants (Moringa) or recombinant DNA; enzyme inhibitors; prevention and treatment of metabolic, cardiovascular, and inflammatory diseases |
| 05/06/2008 | US7368424 peptide antibiotics comprising lysobactin derivatives used for treatment and/or prophylaxis of bacterial infectious diseases; cyclic peptides |
| 05/06/2008 | US7368295 Nanoparticles comprising biologically active TNF which is immobilized on the same |
| 05/06/2008 | US7368108 Glycopeptide remodeling using amidases |
| 05/06/2008 | CA2163637C Topologically segregated, encoded solid phase libraries |
| 05/02/2008 | CA2666962A1 Human salty taste receptor and methods of modulating salty taste perception |
| 05/01/2008 | US20080103061 Functionalized compositions for improved immobilization |
| 04/30/2008 | EP1406927B1 Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |